Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 5, 2000, Pages 1890-1894

  Engelbach, M ^a,c   Gorges R ^b   Forst, T ^a   Pfutzner A ^a   Dawood, R ^a   Heerdt, S ^a   Kunt, T ^a   Bockisch, A ^b   Beyer, J ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c Department of Internal Medicine and Endocrinology ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; PENTAGASTRIN;

ADULT; AGED; ARTICLE; CALCITONIN BLOOD LEVEL; CANCER RECURRENCE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RELIABILITY; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

ADULT; AGED; AGED, 80 AND OVER; CALCITONIN; CARCINOMA, MEDULLARY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEX CHARACTERISTICS; THYROID NEOPLASMS; THYROIDECTOMY; TUMOR MARKERS, BIOLOGICAL;

EID: 0034456830     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.5.1890     Document Type: Article

References (20)

1. Medullary Thyroid Carcinoma/Multiple Endocrine Neoplasia Type 2
2. Routine measurement of plasma calcitonin in nodular thyroid diseases
3. Surgical management of patients with persistent or recurrent medullary thyroid cancer
4. Estimates of circulating monomeric calcitonin: Physiological studies in normal and thyroidectomized man
5. An ultrasensitive chemiluminescence immunometric assay for the quantitative determination of calcitonin
6. Construction and clinical validation of a sensitive and specific assay for serum mature calcitonin using monoclonal anti-peptide antibodies
7. Monoclonal immunoradiometric assay of calcitonin improves investigation of familial medullary thyroid carcinoma
8. Identification and characterization of calcitonin forms in plasma and urine of normal subjects and medullary carcinoma patients
9. Progression of postoperative residual medullary thyroid carcinoma as monitored by plasma calcitonin levels
10. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: Comparison with genetic screening in hereditary medullary thyroid carcinoma
11. The surgical treatment of medullary thyroid carcinoma
12. Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma
13. Multiple endocrine neoplasia type 2: Management of patients and subjects at risk. French Study Group on Calcitonin-Secreting Tumors (GETC)
14. Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin
15. Validation, role in perioperative assessment, and clinical applications of an immunoradiometric assay for human calcitonin
16. Is there an ectopic secretion of monomeric calcitonin in the human being?
17. Calcitonin secretion in children with insulin-dependent diabetes mellitus
18. Disappearance rate of serum calcitonin after total thyroidectomy for medullary thyroid carcinoma
19. Medullary thyroid cancer: Analyses of survival and prognostic factors and the role of radiation therapy in local control
20. Medullary, thyroid carcinoma: Prognosis of familial vs. sporadic disease and the role of radiotherapy